Goldman Sachs’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-50,000
Closed -$4.75M 5302
2019
Q1
$4.75M Buy
+50,000
New +$4.29M ﹤0.01% 3009
2018
Q4
Sell
-23,800
Closed -$2.52M 5575
2018
Q3
$2.52M Buy
+23,800
New +$2.23M ﹤0.01% 3448
2016
Q2
Sell
-75,000
Closed -$2.49M 7193
2016
Q1
$2.49M Buy
75,000
+29,500
+65% +$926K ﹤0.01% 3286
2015
Q4
$1.72M Buy
+45,500
New +$1.53M ﹤0.01% 3777
2015
Q3
Sell
-50,000
Closed -$1.55M 7449
2015
Q2
$1.55M Sell
50,000
-50,000
-50% -$1.47M ﹤0.01% 4103
2015
Q1
$3.33M Buy
100,000
+50,000
+100% +$1.69M ﹤0.01% 3291
2014
Q4
$2.3M Hold
50,000
﹤0.01% 3707
2014
Q3
$1.84M Buy
+50,000
New +$1.83M ﹤0.01% 4019
2014
Q1
Sell
-188,100
Closed -$6.98M 6887
2013
Q4
$6.98M Buy
+188,100
New +$6.95M ﹤0.01% 2712

Other funds holding PODD

Goldman Sachs's PODD Position: Q1 2026 in Review

Goldman Sachs increased its Insulet (PODD) stake by 12% in Q1 2026, buying an estimated $24M and bringing the position to 863,916 shares worth $181M. The position accounts for 0.02% of the portfolio, ranked #722.

Goldman Sachs first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $311M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Goldman Sachs held 863,916 shares of Insulet worth $181M as of Q1 2026.
  • Goldman Sachs bought 95,581 Insulet shares in Q1 2026, an estimated $24M.
  • Insulet made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #722 holding.
  • Goldman Sachs first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Insulet position peaked at $311M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.